High expression of CD11c indicates favorable prognosis in patients with gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 31, 2015, Pages 9403-9412

  Wang, Yuan ^a,b   Xu, Bin ^a   Hu, Wen Wei ^a   Chen, Lu Jun ^a   Wu, Chang Ping ^a   Lu, Bin Feng ^c   Shen, Yue Ping ^d   Jiang, Jing Ting ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

CD11c; Dendritic cell; Gastric cancer; Tumor microenvironment

Indexed keywords

GLYCOPROTEIN P 15095; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARDIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; SAMPLING; STOMACH CANCER; STOMACH POLYP; SURVIVAL RATE; CANCER STAGING; CHI SQUARE DISTRIBUTION; CHINA; DISEASE COURSE; GASTRECTOMY; GENETICS; IMMUNOLOGY; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STOMACH NEOPLASMS; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; UNIVERSITY HOSPITAL; UPREGULATION;

ANTIGENS, CD11C; BIOMARKERS, TUMOR; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GASTRECTOMY; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84940025761     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i31.9403     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, He J. Annual report on status of cancer in China, 2010. Chin J Cancer Res 2014; 26: 48-58 [PMID: 24653626 DOI: 10.3978/j.issn.1000-9604.2014.01.08]
3. Kim HJ, Karpeh MS. Surgical approaches and outcomes in the treatment of gastric cancer. Semin Radiat Oncol 2002; 12: 162-169 [PMID: 11979417 DOI: 10.1053/srao.2002.30818]
4. Ali I, Lone MN, Al-Othman ZA, Al-Warthan A, Sanagi MM. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development. Curr Drug Targets 2015; 16: 711-734 [PMID: 25751009]
5. Ju X, Clark G, Hart DN. Review of human DC subtypes. Methods Mol Biol 2010; 595: 3-20 [PMID: 19941102 DOI: 10.1007/978-1-60761-421-0-1]
6. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426 [PMID: 17898760 DOI: 10.1038/nature06175]
7. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Günther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001; 194: 1823-1834 [PMID: 11748283]
8. Gulubova MV, Ananiev JR, Vlaykova TI, Yovchev Y, Tsoneva V, Manolova IM. Role of dendritic cells in progression and clinical outcome of colon cancer. Int J Colorectal Dis 2012; 27: 159-169 [PMID: 22065108 DOI: 10.1007/s00384-011-1334-1]
9. Sandel MH, Dadabayev AR, Menon AG, Morreau H, Melief CJ, Offringa R, van der Burg SH, Janssen-van Rhijn CM, Ensink NG, Tollenaar RA, van de Velde CJ, Kuppen PJ. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 2005; 11: 2576-2582 [PMID: 15814636 DOI: 10.1158/1078-0432.CCR-04-1448]
10. Swartz MA. Immunomodulatory roles of lymphatic vessels in cancer progression. Cancer Immunol Res 2014; 2: 701-707 [PMID: 25092811 DOI: 10.1158/2326-6066.CIR-14-0115]
11. Ramanathapuram LV, Hopkin D, Kurago ZB. Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16(+) DC Phenotype and Control DC Migration. Cancer Microenviron 2013; 6: 41-55 [PMID: 21809059 DOI: 10.1007/s12307-011-0077-4]
12. Castro FV, Tutt AL, White AL, Teeling JL, James S, French RR, Glennie MJ. CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur J Immunol 2008; 38: 2263-2273 [PMID: 18651710 DOI: 10.1002/eji.200838302]
13. Tanji Y, Mizoguchi K, Yoichi M, Morita M, Hori K, Unno H. Fate of coliphage in a wastewater treatment process. J Biosci Bioeng 2002; 94: 172-174 [PMID: 16233288]
14. Chen J, Yang J, Jiang J, Zhuang Y, He W. Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer. Int J Clin Exp Pathol 2014; 7: 8304-8311 [PMID: 25550889]
15. Okita Y, Tanaka H, Ohira M, Muguruma K, Kubo N, Watanabe M, Fukushima W, Hirakawa K. Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer. J Surg Res 2014; 186: 192-200 [PMID: 24120241 DOI: 10.1016/j.jss.2013.08.024]
16. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, Hauben E, Roncarolo MG. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010; 116: 935-944 [PMID: 20448110 DOI: 10.1182/blood-2009-07-234872]
17. Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008; 222: 155-161 [PMID: 18364000 DOI: 10.1111/j.1600-065X.2008.00607.x]
18. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106: 259-262 [PMID: 11509173]
19. Ratzinger G, Baggers J, de Cos MA, Yuan J, Dao T, Reagan JL, Münz C, Heller G, Young JW. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 2004; 173: 2780-2791 [PMID: 15294997]
20. Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology 2009; 55: 301-312 [PMID: 19723145 DOI: 10.1111/j.1365-2559.2009.03379.x]
21. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol 2012; 65: 159-163 [PMID: 22049225 DOI: 10.1136/jclinpath-2011-200355]
22. Ishigami S, Ueno S, Matsumoto M, Okumura H, Arigami T, Uchikado Y, Setoyama T, Arima H, Sasaki K, Kitazono M, Shinchi H, Kijima Y, Natsugoe S. Prognostic value of CD208-positive cell infiltration in gastric cancer. Cancer Immunol Immunother 2010; 59: 389-395 [PMID: 19760221 DOI: 10.1007/s00262-009-0758-8]
23. Ladányi A, Kiss J, Somlai B, Gilde K, Fejos Z, Mohos A, Gaudi I, Tímár J. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 2007; 56: 1459-1469 [PMID: 17279413 DOI: 10.1007/s00262-007-0286-3]
24. Cooney LA, Gupta M, Thomas S, Mikolajczak S, Choi KY, Gibson C, Jang IK, Danziger S, Aitchison J, Gardner MJ, Kappe SH, Wang R. Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c. Infect Immun 2013; 81: 4171-4181 [PMID: 23980113 DOI: 10.1128/IAI.00871-13]
25. Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, Brockstedt D, Dubensky TW, Stins MF, Lanier LL, Pardoll DM, Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006; 12: 207-213 [PMID: 16444266 DOI: 10.1038/nm1352]
26. Caminschi I, Ahmet F, Heger K, Brady J, Nutt SL, Vremec D, Pietersz S, Lahoud MH, Schofield L, Hansen DS, O'Keeffe M, Smyth MJ, Bedoui S, Davey GM, Villadangos JA, Heath WR, Shortman K. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 2007; 204: 2579-2590 [PMID: 17923506 DOI: 10.1084/jem.20071351]
27. Fahlén-Yrlid L, Gustafsson T, Westlund J, Holmberg A, Strömbeck A, Blomquist M, MacPherson GG, Holmgren J, Yrlid U. CD11c(high) dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization. J Immunol 2009; 183: 5032-5041 [PMID: 19786541 DOI: 10.4049/jimmunol.0803992]
28. Choi BK, Kim YH, Kang WJ, Lee SK, Kim KH, Shin SM, Yokoyama WM, Kim TY, Kwon BS. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Cancer Res 2007; 67: 8891-8899 [PMID: 17875731 DOI: 10.1158/0008-5472.CAN-07-1056]
29. Vinay DS, Kwon BS. CD11c+CD8+ T cells: two-faced adaptive immune regulators. Cell Immunol 2010; 264: 18-22 [PMID: 20620256 DOI: 10.1016/j.cellimm.2010.05.010]
30. Huang CM, Xu M, Wang JB, Zheng CH, Li P, Xie JW, Lin JX, Lu J. Is tumor size a predictor of preoperative N staging in T2-T4a stage advanced gastric cancer? Surg Oncol 2014; 23: 5-10 [PMID: 24508061 DOI: 10.1016/j.suronc.2014.01.003]
31. Lu J, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surg Oncol 2013; 22: 167-171 [PMID: 23787074 DOI: 10.1016/j.suronc.2013.05.002]
32. Suzuki C, Blomqvist L, Sundin A, Jacobsson H, Byström P, Berglund Å, Nygren P, Glimelius B. The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol 2012; 23: 948-954 [PMID: 21832285 DOI: 10.1093/annonc/mdr350]